TNDM vs. IYW

In the year-to-date period, TNDM achieves a -36.90% return, which is significantly lower than IYW's 0.26% return. Over the past 10 years, TNDM has underperformed IYW with an annualized return of -15.21%, while IYW has yielded a comparatively higher 20.05% annualized return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Tandem Diabetes Care, Inc. (TNDM) and iShares U.S. Technology ETF (IYW). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current TNDM Sharpe Ratio is -0.77, which is lower than the IYW Sharpe Ratio of 0.54. The chart below compares the historical Sharpe Ratios of TNDM and IYW, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

TNDM has not paid dividends to shareholders, while IYW's dividend yield for the trailing twelve months is around 0.21%.

The maximum TNDM drawdown since its inception was -99.25%, which is greater than IYW's maximum drawdown of -81.89%. Use the drawdown chart below to compare losses from any high point for TNDM and IYW. For additional features, visit the drawdowns tool.

Tandem Diabetes Care, Inc. (TNDM) has a higher volatility of 21.05% compared to iShares U.S. Technology ETF (IYW) at 7.73%. This indicates that TNDM's price experiences larger fluctuations and is considered to be riskier than IYW based on this measure. The chart below showcases a comparison of their rolling one-month volatility.